Makito Miyake

5.8k total citations
305 papers, 3.9k citations indexed

About

Makito Miyake is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Makito Miyake has authored 305 papers receiving a total of 3.9k indexed citations (citations by other indexed papers that have themselves been cited), including 143 papers in Surgery, 129 papers in Pulmonary and Respiratory Medicine and 61 papers in Molecular Biology. Recurrent topics in Makito Miyake's work include Bladder and Urothelial Cancer Treatments (110 papers), Urinary and Genital Oncology Studies (66 papers) and Prostate Cancer Diagnosis and Treatment (52 papers). Makito Miyake is often cited by papers focused on Bladder and Urothelial Cancer Treatments (110 papers), Urinary and Genital Oncology Studies (66 papers) and Prostate Cancer Diagnosis and Treatment (52 papers). Makito Miyake collaborates with scholars based in Japan, United States and China. Makito Miyake's co-authors include Kiyohide Fujimoto, Charles J. Rosser, Nobumichi Tanaka, Yasushi Nakai, Steve Goodison, Satoshi Anai, Shunta Hori, Yosuke Morizawa, Kazumasa Torimoto and Yoshihiro Tatsumi and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Makito Miyake

279 papers receiving 3.8k citations

Peers

Countries citing papers authored by Makito Miyake

Since Specialization

Citations

This map shows the geographic impact of Makito Miyake's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Makito Miyake with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Makito Miyake more than expected).

Fields of papers citing papers by Makito Miyake

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Makito Miyake. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Makito Miyake. The network helps show where Makito Miyake may publish in the future.

Co-authorship network of co-authors of Makito Miyake

This figure shows the co-authorship network connecting the top 25 collaborators of Makito Miyake. A scholar is included among the top collaborators of Makito Miyake based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Makito Miyake. Makito Miyake is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Efficacy and Safety of Nivolumab Plus Ipilimumab for Metastatic Renal Cell Carcinoma in Patients 75 Years and Older: Multicenter Retrospective Study 2025 ·Cancers ·Shimpei Yamashita, Shuzo Hamamoto, Junya Furukawa, Kazutoshi Fujita, Masayuki Takahashi, Makito Miyake, Noriyuki Ito, Hideki Iwamoto, Yasuo Kohjimoto, Isao Hara	0
2	Real-world treatment patterns and outcomes of patients with unresectable or metastatic urothelial carcinoma receiving systemic therapy in Japan 2024 ·Urologic Oncology Seminars and Original Investigations ·(unknown), (unknown), S Kojima, Kotoba Okuyama, (unknown), (unknown), (unknown), (unknown), Makito Miyake	2
3	Trisomy 13 with retroiliac ureter diagnosed by assessment for recurrent febrile urinary tract infections 2024 ·IJU Case Reports ·Yosuke Morizawa, (unknown), Takuto Shimizu, (unknown), Shunta Hori, Daisuke Gotoh, Yasushi Nakai, Makito Miyake, Kazumasa Torimoto, Kiyohide Fujimoto	0
4	Association of lung immune prognostic index with survival outcomes in patients with metastatic renal cell carcinoma treated with nivolumab plus ipilimumab 2024 ·Japanese Journal of Clinical Oncology ·Shimpei Yamashita, Shuzo Hamamoto, Junya Furukawa, Kazutoshi Fujita, Masayuki Takahashi, Makito Miyake, Noriyuki Ito, Hideki Iwamoto, Yasuo Kohjimoto, Isao Hara	2
5	External validation of hemoglobin and neutrophil levels as predictors of the effectiveness of ipilimumab plus nivolumab for treating renal cell carcinoma 2024 ·Frontiers in Oncology ·Shuzo Hamamoto, (unknown), Shimpei Yamashita, Junya Furukawa, Kazutoshi Fujita, (unknown), Makito Miyake, Noriyuki Ito, Hideki Iwamoto, (unknown), Kazumi Taguchi, Takahiro Yasui	0
6	Photodynamic diagnosis‐assisted transurethral resection of bladder tumor for high‐risk non‐muscle invasive bladder cancer improves intravesical recurrence‐free survival (BRIGHT study) 2024 ·International Journal of Urology ·Taketo Kawai, Hideyasu Matsuyama, Keita Kobayashi, Atsushi Ikeda, Makito Miyake, Koshiro Nishimoto, Yuto Matsushita, Hiroyuki Nishiyama, Kiyohide Fujimoto, Masafumi Oyama, Hideaki Miyake, Haruhito Azuma, Keiji Inoue, Takahiko Mitsui, Mutsushi Kawakita, Chikara Oyama, Atsushi Mizokami, Takashige Abe, (unknown), Haruki Kume	5
7	Measurement of tissue optical properties in the 400 to 700 nm range to assess light penetration depths for laser treatment of upper tract urothelial carcinomas 2024 ·Journal of Biomedical Optics ·(unknown), (unknown), (unknown), Hidenori Ito, Hideo Fukuhara, Makito Miyake, (unknown), Kiyohide Fujimoto, Takahiro Nishimura	2
8	Trends in Patient Characteristics on the Japanese Waiting Lists for Deceased-Donor Kidney Transplantation. Are There no Eligibility or Ineligibility Criteria for Registration and Renewal? 2024 ·Transplantation Proceedings ·Shunta Hori, (unknown), Kuniaki Inoue, Tatsuo Yoneda, (unknown), Yosuke Morizawa, Daisuke Gotoh, Yasushi Nakai, Makito Miyake, Kazumasa Torimoto, Nobumichi Tanaka, Kiyohide Fujimoto	0
9	Efficacy of a hydrogel spacer for improving quality of life in patients with prostate cancer undergoing low‐dose‐rate brachytherapy alone or in combination with intensity‐modulated radiotherapy: An observational study using propensity score matching 2024 ·The Prostate ·Yasushi Nakai, Nobumichi Tanaka, Isao Asakawa, Kenta Ohnishi, Makito Miyake, (unknown), Kazumasa Torimoto, Kiyohide Fujimoto	3
10	Impact of Complete Surgical Resection of Metastatic Lesions in Patients with Advanced Renal Cell Carcinoma in the Era of Tyrosine Kinase Inhibitors and Immune Checkpoint Inhibitors 2024 ·Cancers ·Takuto Shimizu, Makito Miyake, Nobutaka Nishimura, Takanori Yoshida, Yoshitaka Itami, Akira Tachibana, (unknown), Yuki Oda, (unknown), (unknown), (unknown), Shunta Hori, Yosuke Morizawa, (unknown), Yasushi Nakai, Kazumasa Torimoto, Nobumichi Tanaka, Kiyohide Fujimoto	1
11	MRI/RNA-Seq-Based Radiogenomics and Artificial Intelligence for More Accurate Staging of Muscle-Invasive Bladder Cancer 2023 ·International Journal of Molecular Sciences ·Touseef Ahmad Qureshi, Xingyu Chen, Yibin Xie, (unknown), (unknown), Yuki Kita, Takashi Kobayashi, Makito Miyake, Simon Knott, Debiao Li, Charles J. Rosser, Hideki Furuya	9
12	Response of Patients with Taxane-Refractory Advanced Urothelial Cancer to Enfortumab Vedotin, a Microtubule-Disrupting Agent 2023 ·SHILAP Revista de lepidopterología ·Makito Miyake, Nobutaka Nishimura, Tatsuki Miyamoto, Takuto Shimizu, Kenta Ohnishi, Shunta Hori, Yosuke Morizawa, Daisuke Gotoh, Yasushi Nakai, Kazumasa Torimoto, Tomomi Fujii, Kiyohide Fujimoto	2
13	Recent advancements in the diagnosis and treatment of non‐muscle invasive bladder cancer: Evidence update of surgical concept, risk stratification, andBCG‐treated disease 2023 ·International Journal of Urology ·Makito Miyake, Nobutaka Nishimura, Tomomi Fujii, Kiyohide Fujimoto	5
14	Validation of the risk stratification newly defined in the Japanese Urological Association guidelines 2019 for non‐muscle invasive bladder cancer: A multi‐institutional collaborative study 2023 ·International Journal of Urology ·Tatsuki Miyamoto, Makito Miyake, (unknown), Nobutaka Nishimura, (unknown), (unknown), Masaya Yonemori, Hideki Enokida, Masayuki Nakagawa, Hiroaki Matsumoto, Hideyasu Matsuyama, Yuto Matsushita, (unknown), Tomomi Fujii, Keiji Shimada, Satoshi Baba, (unknown), Tatsuro Shimokama, Koji Okumura, Kiyohide Fujimoto	3
15	Prognostication in Japanese patients with bacillus Calmette‐Guérin‐unresponsive non‐muscle‐invasive bladder cancer undergoing early radical cystectomy 2021 ·International Journal of Urology ·Nobutaka Nishimura, Makito Miyake, Kota Iida, Tatsuki Miyamoto, (unknown), Kazuyuki Numakura, Junichi Inokuchi, Takahiro Yoneyama, Yoshiaki Matsumura, Shugo Yajima, Hitoshi Masuda, Naoki Terada, Rikiya Taoka, Takashi Kobayashi, Takahiro Kojima, Yoshiyuki Matsui, Naotaka Nishiyama, Hiroshi Kitamura, Hiroyuki Nishiyama, Kiyohide Fujimoto	1
16	Living‐donor kidney transplantation for a patient with hypoparathyroidism, deafness, and renal dysplasia syndrome 2020 ·SHILAP Revista de lepidopterología ·Nobutaka Nishimura, Shunta Hori, (unknown), Makito Miyake, Satoshi Anai, Kazumasa Torimoto, Katsuya Aoki, Nobumichi Tanaka, Tatsuo Yoneda, Kiyohide Fujimoto	4
17	Development and external validation of a preoperative nomogram for predicting pathological locally advanced disease of clinically localized upper urinary tract carcinoma 2020 ·Cancer Medicine ·Takashi Yoshida, Takashi Kobayashi, (unknown), Makito Miyake, Katsuhiro Ito, Hiroshi Okuno, Takashi Murota, (unknown), Mutsushi Kawakita, Gen Kawa, Tomoki Kitawaki, Kiyohide Fujimoto, Hideyasu Matsuyama, Hiroaki Shiina, Haruhito Azuma, Osamu Ogawa, Hidefumi Kinoshita, Tadashi Matsuda	13
18	Is Endoscopic Transurethral Incision Really Effective for Boys with Refractory Daytime Incontinence? 2020 ·SHILAP Revista de lepidopterología ·Yosuke Morizawa, Katsuya Aoki, Shunta Hori, Daisuke Gotoh, Makito Miyake, Yasushi Nakai, Kazumasa Torimoto, Nobumichi Tanaka, (unknown)	0
19	PAI-1 Leads to G1-Phase Cell-Cycle Progression through Cyclin D3/cdk4/6 Upregulation 2014 ·Molecular Cancer Research ·(unknown), Makito Miyake, Adrienne Lawton, Steve Goodison, Charles J. Rosser	45
20	Targeting Plasminogen Activator Inhibitor-1 Inhibits Angiogenesis and Tumor Growth in a Human Cancer Xenograft Model 2013 ·Molecular Cancer Therapeutics ·Evan Gomes-Giacoia, Makito Miyake, Steve Goodison, Charles J. Rosser	61

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact